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Abstract
To test the hypothesis that NPY-induced overfeeding activates compensatory responses that inhibit hypothalamic NPY gene expression,
we investigated the effect of chronically administered neuropeptide Y (NPY) on plasma hormones involved in energy balance and on the
level of mRNA for hypothalamic neuropeptides. After cannulation of the third cerebral ventricle, male Long-Evans rats received a 4.5-day
intracerebroventricular (icv) infusion of either human NPY (12 mg per day), or synthetic cerebrospinal fluid (CSF). NPY-treated animals
were either allowed ad libitum access to food or were pairfed to the intake of CSF-treated controls. In rats fed ad libitum, icv NPY
induced significant increases in food intake (75%), body weight (9%), plasma insulin (150%) and plasma leptin levels (300%) as
compared to the icv CSF group. Levels of plasma leptin, but not insulin, remained elevated in NPY-treated rats that were pairfed to the
intake of the CSF group. NPY mRNA levels in the midregion of the arcuate nucleus (ARC) were reduced by 50% in NPY-treated rats that
were allowed to overeat, but not in the pairfed group, as determined by in situ hybridization. In contrast, mRNA for corticotropin-
releasing hormone (CRH) in the paraventricular nucleus (PVN) and proopiomelanocortin (POMC) in the rostral ARC were not
significantly different among groups. These findings indicate that NPY-induced overfeeding suppresses ARC NPY mRNA expression, and
that this effect unlikely to be mediated by a direct action of NPY, since it was abolished by limiting food intake in NPY-treated animals to
that observed in controls. NPY-induced overfeeding was also associated with elevated plasma levels of leptin and insulin. The effect of
these hormones to inhibit NPY gene expression may therefore have contributed to the decrease of NPY mRNA. Ó 1998 Elsevier
Science B.V. All rights reserved.
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Numerous studies have found that NPY has a potent increases levels of plasma corticosterone [3,9], plasma
effect to increase food intake and body weight and can insulin [1,3–5,7,9] and leptin mRNA in inguinal white
alter neuroendocrine function in rodents when injected adipose tissue [7,9], while chronic infusion of NPY
chronically near hypothalamic areas that mediate energy antibody lowers food intake [6]. Some of these responses
homeostasis [1–9]. For example, when animals are al- (e.g. increased leptin mRNA expression [7] and glucocor-
lowed free access to food, chronic icv NPY administration ticoids [1]) persist when hyperphagia is prevented by
pairfeeding, suggesting that they result from an action of
* NPY independent of increased caloric intake.Corresponding author. Tel.: 1 1 206 7642138; fax: 1 1 206
7642164; e-mail: mschwart@u.washington.edu Evidence for a physiological role for NPY in energy
0167-0115/98/$ – see front matter Ó 1998 Elsevier Science B.V. All rights reserved.
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homeostasis derives from studies of factors regulating expression of NPY, POMC and CRH mRNA in rats
NPY gene expression in the arcuate nucleus (ARC) of the allowed ad libitum access to food. An NPY-infused group
hypothalamus, and its release in the paraventricular nu- pairfed to CSF-infused controls was included in order to
cleus (PVN). Several studies have found that conditions separate the local effects that exogenous NPY may have on
associated with weight loss, such as starvation [10–15] and hypothalamic neuropeptide levels from the response to
uncontrolled diabetes [16,17], are associated with in- NPY-induced hyperphagia and weight gain.
creased NPY gene expression and immunoreactivity. This
response is implicated as a mediator of hyperphagia that
promotes the recovery of lost weight. 1. Materials and methods
Since NPY expression is increased with conditions of
caloric deficit, one might expect that levels of NPY mRNA 1.1. Animals and procedures
would be suppressed in animal models of overfeeding.
While this hypothesis appears to be at odds with the Male Long-Evans rats (300–350 g) from the breeding
coexistence of increased food intake with elevated ARC colony maintained by the Department of Psychology at the
NPY gene expression in animals such as the leptin-de- University of Washington were housed individually in
ficient ob /ob mouse [18], this combination is expected if wire-mesh hanging cages in a temperature-controlled
negative feedback signaling from adipose tissue is im- vivarium on a 12:12-h light:dark schedule. Unless other-
paired. Insulin and leptin are hormones that circulate at wise specified, animals were given free access to pelleted
levels proportionate to body adiposity and are implicated rat chow (Harlan–Teklad, Madison, WI) and water at all
as negative feedback signals to the hypothalamus that times. All procedures were performed in accordance with
participate in the inhibitory regulation of both food intake institutional guidelines of the Animal Care Committee at
and ARC NPY gene expression. Thus, food intake and the University of Washington.
hypothalamic NPY levels are increased in conditions
associated with deficiency of one or both of these hor- 1.1.1. Cannula placement
mones (e.g. starvation, uncontrolled diabetes, and genetic Rats were habituated with daily handling for one week
leptin deficiency in ob /ob mice), and replacement of the prior to surgery. Animals (n 5 20) were anesthetized by IP
deficient hormone reduces both food intake and hypo- injection of ketamine /xylazine (60 mg/kg ketamine and 8
thalamic NPY production [18,19] and release [20]. There- mg/kg xylazine) and a 21-gauge cannula (Plastics One,
fore, the hypothesis that insulin and leptin inhibit the NPY Roanoke, VA) was placed stereotaxically into the third
system during overfeeding provides a potential explanation ventricle using a previously described method [16,19].
for persistently elevated hypothalamic NPY synthesis in Cannula placement was verified one week after surgery by
animals with defective leptin and/or insulin signaling, icv injection (1 ml) of angiotensin II (10 ng/ml). Animals
despite pronounced hyperphagia. In contrast, NPY mRNA not consuming at least 8 ml water 30 min post injection
expression in normal animals should be inhibited during were excluded (n 5 5) [19]. Three weeks after cannula
NPY-induced overfeeding if it is accompanied by in- placement, rats were implanted subcutaneously with an
creased negative feedback from insulin and leptin. osmotic minipump (Azlet model [2002, Palo Alto, CA)
We therefore hypothesized that NPY-induced overfeed- delivering either 1 mg/ml human neuropeptide Y (Ameri-
ing in normal animals would elevate plasma levels of can Peptide Co., Sunnyvale, CA) in synthetic CSF vehicle
insulin and leptin, and thereby suppress ARC expression of at a rate of 0.5 ml /h, or vehicle alone, via a polyethylene
NPY mRNA, and indeed, preliminary support for this catheter that was connected to the ventricular cannula.
hypothesis was reported previously in abstract form [21].
In addition, we investigated the role of NPY, acting either 1.1.2. Experimental design
locally in the hypothalamus or via modulation of plasma Three weeks after cannula placement, animals were
hormones, as a regulator of other hypothalamic neuro- subdivided into three groups (n 5 5/group) of equal body
peptides involved in the regulation of energy balance. weight. One group received icv NPY infusion with ad
Specifically, we wished to determine if chronic infusion of libitum access to chow. The second group received icv
NPY alters hypothalamic expression of mRNA encoding synthetic CSF and was also fed ad libitum, while the third
either proopiomelanocortin (POMC) or corticotropin-re- group received icv NPY infusion, but was permitted to eat
leasing hormone (CRH). This possibility is suggested by only the amount of food consumed by the CSF control
the observation that conditions associated with increased group. The amount of chow provided to each pairfed
expression of NPY mRNA can coexist with decreased animal on each treatment day was equal to the measured
hypothalamic POMC mRNA or CRH mRNA levels in the amount of chow consumed by its CSF-treated partner
rat [13,22,23]. during a previous 24-h period, and was divided into three
To test these hypotheses, we studied the effects of a equal portions administered at 0200, 1000 and 1800 h.
4.5-day continuous intracerebroventricular NPY infusion Animals received icv infusions of either NPY or CSF for
on food intake, body weight, plasma hormone levels and four days, and were decapitated between 1000–1100 h on
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the fifth day of infusion. Trunk blood, brains, livers and software. Data are presented as group mean values
retroperitoneal fat pads were collected upon decapitation. (6SEM). Comparisons were performed with one-way
Trunk blood was centrifuged and plasma was stored at analysis of variance with Neuman-Keuls post hoc test. A P
2 208C. Retroperitoneal fat pads and livers were weighed value # 0.05 between group mean values was considered
and stored at 2 208C. statistically significant.
1.2. Assays and data analyses
2. Results
In situ hybridization (ISH) to NPY, CRH, and POMC
mRNA. Brains for ISH were immediately frozen on 2.1. Food intake
crushed dry ice, and subsequently sectioned at 14 mm in a
cryostat and mounted on RNAase-free slides. Hybridiza- As summarized in Table 1, food intake was significantly
tion for NPY and CRH mRNA was performed using greater among NPY-infused rats fed ad libitum (P , 0.05)
33P-labeled antisense oligonucleotide probes based upon than in the CSF-infused group on the first day of infusion.
cDNA sequences of rat NPY or CRH genes, as described This effect increased with each successive day until the
elsewhere [16,19] and a riboprobe complementary to rat time of sacrifice (P , 0.002). Cumulative food intake over
POMC mRNA (a generous gift of Dr. Robert Steiner) was the 4.5-day study period was 75% greater in the NPY-
used for hybridization to POMC mRNA after labeling with infused group than in ad libitum fed controls (P , 0.001).
33P, as previously described [24]. Slides for ISH to POMC As planned, food intake of the NPY-treated pairfed group
mRNA were selected from the region of the ARC rostral to was matched precisely to that of the CSF group, and was
the ventromedial hypothalamic nucleus, and slides for significantly less than that of NPY-treated rats provided ad
NPY mRNA were selected from the midregion of the libitum access to food.
ARC. Slides for CRH mRNA were selected from the PVN.
All slides were selected by an investigator blinded to the 2.2. Body weight
treatment group. Labeled slides were washed under high
stringency conditions and opposed to X-ray film to gener- As summarized in Table 1, mean body weight at
ate autoradiographs, which were analyzed by computer baseline was similar among the three groups of rats. When
densitometry. Using a standard curve, autoradiographic expressed as a percentage of initial body weight, weight at
optical density and hybridization area were determined on the time of sacrifice was increased by 8.7%60.7% in
6–8 sections / rat using the MCID computer densitometry NPY-treated rats fed ad libitum as compared to the CSF-
system (Imaging Research, St. Catherine’s, Ontario, infused ad libitum-fed animals and 10.2%60.7% as com-
Canada). The product of hybridization area (pixels) and pared to the NPY-infused pairfed animals (P , 0.001 for
density (m Ci/pixel) was used as an index of overall both comparisons). Body weight was not significantly
neuropeptide mRNA levels [16,18,24,25]. different between NPY-infused pairfed rats and the CSF-
infused controls. Food in the gastrointestinal tract at
1.2.1. Plasma assays sacrifice was also significantly greater in the NPY ad
Radioimmunoassays were used to measure plasma levels libitum group as compared to both of the other groups
of corticosterone and immunoreactive insulin (IRI) as ( 1 15.5%64.7% vs CSF and 1 10.7%62.9% vs NPY
previously described [19,26]. Plasma glucose was deter- pairfed; P , 0.05 for both comparisons).
mined by the glucose oxidase method (Beckman Instru- When expressed as a percentage of total body weight
ments, Brea, CA). Plasma leptin levels were determined minus the weight of food in the gastrointestinal tract at
using a rat-specific antibody (Linco, St. Louis, MO). sacrifice, liver and retroperitoneal fat pad weights in the
NPY-infused ad libitum group were increased over CSF-
1.2.2. Statistical analyses infused and pairfed groups by 30% and 40%, respectively,
All statistical analyses were carried out using Prism 2.01 although this effect reached statistical significance only for
(GraphPad Software, Inc., San Diego, CA) statistical liver weight (Table 1). The weight of both liver and
Table 1
For NPY vs CSF and NPY pairfed
CSF NPY NPY pairfed
bCumulative food intake over 4.5 days, g 115.3065.99 201.60616.00 115.3065.99
aBody weight at sacrifice, g 408.34614.74 448.04620.20 410.20614.87
cDelta BW/initial BW% 2 0.3360.24 8.3460.76 2 1.8360.59
Retroperitoneal fat pads /BW% 1.3160.12 1.8860.21 1.3560.12
aLiver weight /BW% 3.6760.16 5.0760.46 3.8860.11
a b cP , 0.05, P , 0.001, P , 0.0001.
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retroperitoneal fat pads of CSF-infused animals were not glucose levels were not significantly different between
different from those of NPY-treated pairfed controls. groups (Fig. 1D).
2.4. In situ hybridization
2.3. Plasma values
As depicted in Fig. 2A, ARC NPY mRNA levels were
Plasma leptin was increased by 300% in the NPY significantly lower in the NPY ad libitum group as
infused ad libitum group as compared to the CSF group compared to the levels seen in either the CSF or NPY
(P , 0.001) and was 60% higher in the NPY infused ad pairfed groups (255.3 and 2 45.2%, respectively; P ,
libitum group as compared to the NPY pairfed group 0.05 for both comparisons). PVN CRH mRNA and ARC
(P , 0.01) (Fig. 1A). Differences in leptin levels were also POMC mRNA also tended to be decreased in the NPY ad
significant between CSF and NPY pairfed groups, with the libitum group as compared to the CSF and NPY pairfed
NPY-infused pairfed group having a nearly 200% elevation groups, although these differences did not reach statistical
over the CSF group (P , 0.01) (Fig. 1A). significance (Fig. 2B, C). The only statistically significant
Plasma corticosterone levels were increased by 90% in effect of icv NPY on hypothalamic mRNA levels measured
the NPY infused ad libitum group as compared to the in this study, therefore, was on expression of NPY mRNA.
CSF-infused group (105.6ng/ml637.51 vs 55.76ng/ This effect, however, was prevented by limiting food
ml633.71), and by 180% in the NPY pairfed group intake to that of the CSF-treated controls.
(160.46ng/ml611.94) (Fig. 1B), although neither differ-
ence reached statistical significance. Plasma insulin levels
were 150% higher in the NPY ad libitum group than in 3. Discussion
either the CSF or the NPY pairfed group (P , 0.01) (Fig.
1C). In contrast to the effect of icv NPY to increase leptin Conditions associated with weight loss increase hypo-
levels in pairfed rats, however, insulin levels were not thalamic NPY production and release [10–16], and this
different between pairfed and CSF-treated controls. Plasma response is implicated in the hyperphagic response that
a bFig. 1. Effect of chronic NPY infusion on plasma levels. 1A. Plasma leptin levels, P , 0.001 vs CSF controls, P , 0.01 vs CSF controls. 1B. Plasma
corticosterone levels. 1C. Plasma insulin levels, *P , 0.01 vs CSF and NPY pairfed controls. 1D. Plasma glucose levels. For all figures, the NPY ad libitum
fed group is represented by solid bars, the CSF group by open bars, and the NPY pairfed group by striped bars (n 5 5/group).
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hypothesis, we performed chronic icv NPY administration
to induce an increase of food intake and body weight,
which thereby increased plasma levels of insulin and
leptin. We found that rats infused with NPY for 4.5 days
had a 55.3% reduction of NPY mRNA expression in the
midregion of the ARC as compared to CSF-infused
controls, and that this response was accompanied by
significant elevations of plasma leptin and insulin.
The mechanism by which hypothalamic NPY expression
was downregulated may have involved overfeeding-in-
duced elevation of plasma leptin and insulin. Alternatively,
exogenous administration of NPY may have acted locally
in the brain to suppress ARC NPY mRNA expression. To
distinguish between these two possibilities, we controlled
for overfeeding and its hormonal sequelae by including a
group of NPY-infused rats with food intake yoked to ad
libitum-fed, CSF-infused animals. Since ARC NPY mRNA
was not suppressed in this pairfed group, our results
support the hypothesis that it is NPY-induced overfeeding,
rather than a direct action of NPY in the brain, that is
responsible for suppression of NPY mRNA. Since several
endpoints of our study are sensitive to the size and timing
of meals (e.g. plasma insulin and glucose levels), it is
possible that they were influenced by the pairfeeding
regimen itself. Our observation that significant differences
were not detected between the NPY-pairfed and the CSF
control groups in any endpoint except for leptin levels,
however, suggests that an independent effect of the
pairfeeding regimen is unlikely to explain our results.
Plasma insulin levels were elevated by 150% and
plasma leptin levels by 300% in the NPY-infused ad
libitum group relative to the CSF-infused controls. Since
neither insulin levels nor NPY mRNA levels were elevated
in the pairfed group relative to the CSF controls, while
leptin levels remained significantly elevated above CSF
controls, our results suggest that the combination of
increased leptin and insulin signaling may be required for
overfeeding-induced suppression of ARC NPY mRNA
expression.
Previous studies [27,28] have found that plasma leptin
levels vary in proportion to fat stores and caloric intake.
The effect of NPY-induced overfeeding to increase leptin
levels was therefore expected. However, the pairfed group
Fig. 2. Effect of chronic NPY infusion on hypothalamic neuropeptide
also had a marked elevation in plasma leptin levels in
expression determined by in situ hybridization. 2A. Levels of NPY
response to icv NPY infusion despite the fact that bodymRNA in the midregion of the arcuate nucleus, *P , 0.05 vs CSF and
composition and food intake were not different from thoseNPY pairfed controls. 2B. Levels of CRH mRNA in the PVN. 2C. Levels
of POMC mRNA in the region of the arcuate nucleus rostral to the of the CSF group. That leptin levels were elevated in the
ventromedial hypothalamic nucleus. For all figures, the NPY ad libitum face of maintained body weight and fat stores is a
fed group is represented by solid bars, the CSF group by open bars, and paradoxical finding that suggests a direct action of NPY in
the NPY pairfed group by striped bars (n 5 5/group except for 2A and
the brain to stimulate adipocyte leptin secretion. A previ-2C, where n 5 4 for NPY pairfed).
ous study asserted that insulin may mediate this upregula-
tion [7], yet our findings indicate that leptin levels in-
replenishes depleted fuel stores. Overfeeding might there- creased independent of hyperinsulinemia, and recent evi-
fore be predicted to suppress the NPY system, especially if dence indicates that adipocyte glucose metabolism may
it increases levels of hormones such as insulin and leptin mediate this action [29]. An alternative mechanism to
that inhibit ARC NPY gene expression. To test this explain this NPY effect involves an inhibition of sympa-
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thetic outflow induced by NPY [30]. Conditions that prevention of the NPY-induced increase in food intake by
increase sympathetic nervous system outflow lower leptin pairfeeding blocked the suppression of NPY mRNA ex-
levels [31], and NPY reduces SNS outflow. Therefore, it is pression and lowered plasma leptin and insulin levels. In
possible that NPY may have acted in the central nervous addition, our data suggest that NPY can activate a central
system to elevate leptin levels via diminished SNS tone to nervous system pathway that increases leptin secretion,
the adipocyte. Inhibition by NPY of the mechanisms since plasma leptin levels were elevated in NPY-infused
responsible for leptin clearance from the circulation pro- pairfed animals in the absence of any increase in body
vides a third potential explanation for this result. Further weight. The concept of a neuronal system for regulating
studies are warranted to test these hypotheses. leptin secretion in vivo warrants further study.
Recently it was demonstrated in an overfeeding
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